---
title: "Jaguar Health delays Q2 Form 10-Q filing after holdup compiling subsequent-event information"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295979243.md"
description: "Jaguar Health filed a Form 12b-25 to delay its Q2 2026 Form 10-Q filing due to the time required to compile information on significant subsequent-event transactions. The company expects to submit the delayed report within five calendar days of the original deadline and anticipates no significant changes in operational results compared to the prior year period."
datetime: "2026-08-14T21:28:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295979243.md)
  - [en](https://longbridge.com/en/news/295979243.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295979243.md)
generator: "portal-rs"
---

# Jaguar Health delays Q2 Form 10-Q filing after holdup compiling subsequent-event information

-   Jaguar Health filed a Form 12b-25 to delay its Form 10-Q for the quarter ended June 30, 2026. \* Delay tied to compiling information for the filing, including significant subsequent-event transactions. \* Company expects to file the Form 10-Q within five calendar days of the original due date. \* Notice indicated no anticipated significant change in results of operations versus the comparable prior-year period. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-352657), on August 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [JAGX.US](https://longbridge.com/en/quote/JAGX.US.md)

## Related News & Research

- [JAGX: Q2 2026 revenue fell 60% year-over-year as focus shifted to rare disease drug development](https://longbridge.com/en/news/296396312.md)
- [Jaguar Health signs new crofelemer manufacturing, supply deal with Alivus through March 2029](https://longbridge.com/en/news/292671254.md)
- [Jaguar Health extends Streeterville promissory note maturity to Oct. 1, 2026](https://longbridge.com/en/news/290247838.md)
- [13:46 ETMesa Public Schools Ends Six-Year Streak of Procurement Audit Findings with OpenGov](https://longbridge.com/en/news/296523897.md)
- [Jaguar Health announces press release on crofelemer compassionate use for infant MVID patient in EU](https://longbridge.com/en/news/293477258.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**